Summary
In order to screen UV-absorbing solutes in large numbers of uremic serum samples, an automated liquid chromatographic method was developed. The method proved to be reliable and reproducible in more than 500 analyses. HPLC separation was performed using gradient elution on a 25cm Ultrasphere Octyl reversed phase column, with 5 pm particles. Characteristic profiles for the uremic state were obtained in the analyses of serum samples of 43 uremic patients before and just after artificial kidney treatment; hemodialysis (n = 14), hemodiafiltration (n = 13) and hemofiltration (n = 16). In these profiles 20-40 peaks were resolved of which nine were 'quantitated' by peak height relative to a standard. Of these solutes creatinine, uracil, uric acid, hypoxanthine, indoxylsulfate, tryptophan and hippuric acid were identified. The heterogeneity of the population of uremic patients, with respect to the UV-absorbing solutes, was estimated. Significant differences of solute blood level changes during hemodialysis, hemodiafiltration and hemofiltration, were observed.
Introduction
Many efforts have been made to separate and identify the solutes xcumul;rting in the blood of patients with chronic renal failure. in uremic patients' p~~pulati(~ns on the basis of analytical data. In the present study the automated profiling of UV-absorbing solutes in uremic fluids will be described. and the method is applied in a study of patient heterogeneity and in vivo dialysis efficiency.
Materials and methods
Pre-and postdialysis uremic serum samples were ultrafiltrat~d through membranes with 10000 M, cut-off (Diafld" PMIO. Amicon Corp. Danvers, MA, USA). using an g-cell Multi-micro-ultrafiltration system. MMC (Amicon). at a nitrogen pressure of 2 Bar.
The uItrafiltrated sera were then stored at -18°C until use. Before HPLC analysis 400 ~1 of the ultrafiltrated sample were diluted by addition of 400 ~1 of an injection standard solution of naphthal~ne sulfonic acid (0.037 mg/ml). Fifty microliters of the sample was injected onto the liquid chromatograph.
Fourteen hemodiaiysis patients were treated with a cuprophane dialyzer and a dialyzate flow of 500 ml/mm; 16 hemodiafiltration patients received a 10-l infusion of a substitution fiuid together with a dialyzate flow of 500 ml/mm and an ultrafiltration of at least 10 I on a more permeable polyacrylonitrile or polymethyl methacrylate membrane.
In 16 hemofiltration patients. there was no dialyzate flow. and an infusion of 20 1 of substitution fluid was performed, together with an ultrafiltration of at least 20 I. All patients had chronic renal failure (creatinine clearance < 8 ml/mm} and were on regular artificial kidney treatment.
HPLC uppuratus
The analyses were performed on an automated system. consisting of a model 421 solvent program controller, two model 100 A piston pumps, a model 160 fixed wavelength UV-absorbance detector, operated at 254 nm (0.05 AUFS sensitivity), and a model 500 autosampler (all from Beckman Instr., Berkeley, CA, USA).
An SP4000 laboratory data system was used (Spectra Physics, Santa Clara, CA, USA). UV spectra were recorded on-line with a HP 1040 A photodiode array UV detector (Hewlett Packard, Palo Alto, CA, USA).
HPLC analysis
Separations were carried out on an Ultrasphere Octyl (C8-modified silica) column (4.6 mm i.d. x 25 cm) with 5-pm particles, and a 2 mm i.d. X 3 cm guard column packed with Ultrasphere Octyl lo-pm material. The solvent gradient was 100% aqueous ammonium formate buffer (0.05 mol/l, pH 4) to 60% methanol (Fisons Ltd. Loughborough, UK) within 45 min. After each analysis, the column was regenerated by pumping 100% methanol for 20 min. Flow rate during analysis was 1 ml/min. The solvent and the column (waterjacket Alltech Assoc. Inc., Deerfield, IL, USA) were kept at a constant temperature of 25°C. Water used for the solvent and sample dilution was obtained from a Mini-Q water purification system (MilliporeWaters, Milford, MA, USA).
Between the water pump and the gradient mixer a 15-cm Lichroprep RP18 (Merck, Darmstadt, FRG) column (with 40 pm particles) was mounted to avoid interference of organic impurities in the buffer during gradient elution on the main column.
Calibration lines for creatinine, uracil, indoxylsulfate and hippuric acid, were determined by injection of buffer and methanolic solutions.
Peak heights of the solutes, relative to the height of the injection standard, naphthalene sulfonic acid, were determined. The equations, correlation coefficients and ranges of the regression lines were: creatinine, y = 0.054 + 0.001~ (r = 0.998) 655 pmol/l); uracil, y = 0.1057 + 0.0329x (1. = 0.998) (2-100 pmol/l); indoxylsulfate, y = 0.0053 + 0.0099x (r = 0.999) (2-50 pmol/l); hippuric acid, y = 0.049 + 0.008x (r = 0.999) (17-503 pmol/l).
Determination of creatinine
Creatinine was determined in uremic serum samples with a routine clinical method (picrate complex) using a Beckman Creatinine Analyser 2 system.
Mass spectrometry
Lyophilized HPLC fractions were analyzed by desorption chemical ionization MS. The samples were applied on a platinum wire on top of a direct insertion probe. In the ion source an electric current through the wire was programed (O-2.8 A in 20 s). The reagent gas was ammonia/methane lo/90 v : v for reasons of its high proton affinity, resulting in ionization with little fragmentation for the nitrogenous compounds expected. At an ionizer pressure of 0.10 Torr, NH: was the reactant ion. We used a Finnigan 4000 quadrupole GC-MS system combined with a Data General Nova 4s data system. Statistical evaluation of analytical data was performed with the statistics program CONSTAT.
running on the Institute's Burroughs B7700 mainframe computer.
Experimental

Optimization of the HPLC unu!v.ris
Type of column packing and elution conditions were optimized with respect to the number of peaks separated in a uremic serum ultrafiltrate test pool, distribution of the peaks throughout the chromatogram, separation efficiency in terms of plate number, and analysis time. Commercially available reversed phase columns from different manufacturers, packed with octyl as well as octadecyl modified silica, were tested. The Ultrasphere Octyl (C8-modified) reversed phase column was chosen for reasons of selectivity and efficiency. Reproducibility of retention times between different columns of the same type and manufacturer constitutes a serious problem in modern liquid chromatography especially when large numbers of samples have to be analyzed reproducibly from one column to another. Therefore four columns from the same production batch were tested under isocratic conditions (solvent: methanol/water 60 : 40 v/v). The retention times of the test solutes phenol (k' = 0.77). p-cresol (k' = 1.33) and anisole (k' = 2.37) showed reproducibilities which were better than 2.5% (CV). All columns had efficiencies of more than 88000 theoretical plates/meter (4.9% CV). The HPLC elution conditions were comparable to those published earlier by Senftleber et al [I] ; however, for reasons of volatility we used an ammonium formate buffer. This was necessary for mass spectrometric identification. and the application of in vitro toxicity tests on lyophilized HPLC fractions.
The separation of a uremic ultrafiltrated serum pool on the Ultrasphere ODS (Cl8) and Octyl (C8) columns, under the optimized conditions, is shown in Fig. 1 . As can be seen, more than 40 peaks are resolved within 30 min. In the separation on the octyl column the peaks are more evenly distributed throughout the chromatogram.
Reproducibility of the anulysis
In order to check column and equipment performance a gradient test mixture (Fig. 2) was injected after every ten samples. Retention times and peak heights showed CV values of 0.6-l .O and 1 .O-3.6%, respectively in 10 gradient test injections during a l-mth period. Thus these data represent long-term analysis reproducibility. Total reproducibility, including sample pretreatment (ultrafiltration), of retention times and peak heights of four solutes in a uremic serum pool, were 0.1-0.3 and 3.2-6.2%, respectively (n = 6).
Interference of drugs
The most commonly used drugs in the population of the uremic patients were: Co-trimoxazol, fenoterol, were suspected of interference with the HPLC analvais. Injection of methanolic solutions of these drugs. in the expected concentr~ltiona. resulted in peaks at retention times of 1.935 and 1,999 b for Co-trimoxazol and at 84X s for neurobion.
However. the possible interference of lll~tab~~lites ctf the drugs was not estimated. as only the native drugs were available.
Peaks were identified by HPLC retention times of known injected solutes of which the presence was expected. by comparing UV-spectra of the peaks with those of known solutes with the same retention time, and by mass spectrometric analysis. A list of solutes and their retention times is given in Table I . Until now the compounds creatinine, uracil, uric acid, hypoxanthine. indoxylsulfate. tryptophan and hippuric acid were identified by a combination of the described methods (see Fig. 3 ). UV-spectra of the peak at retention time 350 s and an injected sample of uracii are compared in Fig. 4 . 2, uracil; 3, uric acid; hx, hypoxant~ne; 4, unknown; 5, unknown; 6, unknown; 7, indoxylsulfate; 8, tryptopban; 9, bippuric acid; st, injection standard naphthalene sulfonic acid. This patient belongs to group 2, as described in the text.
Although the spectra of Fig. 4 are not enough for a positive identification. WC based the identification of the solute uracil on retention time, UV-spectrum and mass spectrometric data. The characteristic and, in most cases. abundant peaks 4. 5 and 6 (with retention times of 825, 860 and 960 s) remain to be identified.
Results
Estimution of heterogeneit?
Ultrafiltrated uremic serum samples of 33 patients on regular hemodialysis (n = 17) and hemodiafiltration (n = 16) were analyzed, in order to estimate the heterogeneity of this population with respect to the accumulation of UV-absorbing solutes. Some of the patients were followed for several months to investigate the variability of the patterns with time. The patients could be divided into three main groups according to the predialysis HPLC profiles.
The first group of 5-10 patients showed profiles (Fig. 5A ) which were similar to those of healthy persons (Fig. 3C) , although their creatinine levels were significantly higher.
The second group, comprising some 20 patients, had patterns that seem to be characteristic of uremia (Fig. 3A) , although different gradations of accumulation are observed.
In the profiles of the third group (5510 patients) a large number of additional high peaks are found (Fig. 5B) .
The profiles of a number of patients from these three different groups were determined during a 5-mth period, and were found to be fairly constant although slight variation in peak heights did appear (Fig. 6) .
In Fig. 6 HPLC profiles of two patients recorded at two months intervals, are shown. Preliminary observations indicate that differences in the profiles are at least partly related to residual renal function. No relation to the type of renal failure seems to be present in this population of patients, who all have residual renal function of less than 8 ml/min creatinine clearance.
A correlation of the patterns to patient specific clinical parameters, using multivariate statistical analysis, is presently under investigation. Nine prominent peaks, present in almost all chromatograms (as numbered in Fig.  3 ) were quantitated by measuring predialysis peak heights and dividing by the height of the injection standard. The peak eluting after 560 s, hypoxanthine, was not evaluated, because it showed dialysis ratios greater than, as well as smaller than unity, and also high short term variance in the patients sera. Frequency distributions of the levels of the solutes were determined. Table II presents the pretreatment free serum levels of four solutes. These data were obtained by means of the calibration lines, as described under 'Materials and Methods'. Table III shows matrix of the 9 peaks, and total UV-absorbance (total peak area at 254 nm) for 33 patients on hemodialysis or hemodiafiltration treatment.
(This is the population from columns 4 and 5 in Table IV , with 6 additional patients on HD (3) and HDF (3) of which only predialysis serum samples were available.)
The values of the correlation coefficients and their significance (between parentheses) are given. Some interesting phenomena are observed in this matrix. There is no significant correlation between creatinine levels and those of the other solutes. nor with total peak area, at p = 0.05 (r -c 0.3). This is also illustrated by creatinine peak heights in Fig. 5 . On the other hand, the peak at 960 s (peak no. 6, n.e. c 0.01 4 0.001 Fig. 3 ) correlated well with four other solutes and the total peak area, at different levels of significance. The correlation of peak heights of uracil, peak no. 6, and hippuric acid, with total UV (total peak area) were very significant ( p = 0.0005). Creatinine levels as determined by the picrate method in serum relate quite well to creatinine levels in ultrafiltrated serum determined by HPLC (r = 0.92, p < 0.001). These results suggest that the serum creatinine level, which is commonly determined, is not an optimal measure of the degree of accumulation of UV-absorbing substances in serum of patients on chronic dialysis treatment.
Hippuric acid, uracil and peak no. 6 seem to be more optimal as a measure of accumulation of UV-absorbing substances. Moreover, from Table 111 it can be seen that there is a highly significant correlation between peak heights of hippuric acid and the unknown peak 4, possibly indicating a metabolic relationship between the two.
Estimation of artificial kidney ~~ea~~len~ efficiency
in this study, the efficiency of the in vivo removal of different UV-absorbing substances during hemodialysis (HI)), hemodiafiltration (HDF) and hemofiltration (HF) was estimated. Treatment duration was 4 h, 3 times/wk, in all cases. For each of the nine solutes in the HPLC profiles the concentration ratio of the substance in predialysis and postdialysis serum was determined, as a measure of the efficiency of the treatment (dialysis ratio) [11, 12] . These ratios were determined for each patient treated with one of the three methods. Then a mean dialysis ratio, r>, was calculated per group (or per type of treatment). In Table IV these data are presented. In the last three columns the differences of the dialysis ratio in the three treatment groups are evaluated with the Wilcoxon distribution free test. It is seen that most solutes show the following sequence of treatment efficiency: in,, > J)nn > -C)rrr. This phenomenon is the most prominent for the solutes uracil, hippuric acid and the unidentified peak no. 6. This also holds for the dialysis ratio calculated from predialysis and postdialysis total UV (254 nm).
It must be stressed that the dialysis ratio is only indicative of the efficiency of treatment.
Blood concentrations during and after dialysis are influenced by mass transfer across the dialysis membrane, but also by generation rate and transfer across membranes between compartments.
It is seen that, while the difference of &.,,, un and &reat.Ht,F is not significant at p = 0.05, the correspoiiding values for uracil, hippuric acid peak no. 6, and fbtal UV peak area are ( p -Z 0.025).
The difference of r> values for indoxylsulfate and tryptophan in the three groups are not evaluated for reasons of high variance. In all patients the solutes indoxylsulfate and tryptophan had dialysis ratios smaller than unity. This means that the concentration of the free solutes is higher in the patient's serum just after treatment compared to predialysis levels. Mean values (and SD) of pre-and post dialysis, non-bound indoxylsulfate levels in the sera of 30 uremic patients were 17.9 (9.9 SD) and 35.8 (20.8 SD) pmol/l, respectively. This possibly is a result of heparinization during artificial kidney therapy. It is suggested [13] that heparin releases the enzyme lipoprotein lipase from tissue, which promotes the hydroiyzati~)l~ of triglycerides to form free fatty acids ( FFA ). v,bictl could act as competitors to tryptophan and indoxylsulfate protein binding. resulting in high postdialysis levels of the free solutes.
The data on the relative efficiencies of solute removal in the three methods are in accordance with observations reported in literature. It is known that hemofiltration. which was designed to remove so-called 'middle molecules' is less rfficicnt with respect to low molecular mass substances than henl~~di~~ly~is (141.
Hemodiafiltration, which is applied with the purpose of combining the benefits of both diffusion (hemodialysis) and convection (hemofiltration)
[IS] is shown to remove the low molecular mass solutes better than each of the methods separately. This suggests that the average therapy duration in thr whole group of patients might be shorter in hem~~diafiitrati~~n compared to the 4-h hemodialysis.
The predialysis levels of the nine solutes in h~m~~di~llysis and h~modinfiltratictn were compared. Only peak no. 4 (X25 s), indoxylsulfatc and hippuric acid were present in significantly lower concentrations in predialysis serum of patients on hemodiafiltration ( p = 0.005, 0.05. 0.03 respectively). This phenomenon is presently under investigation.
Conclusion
The automated HPLC profiling technique for UV-absorbing solutes was found to be reliable and reproducible in the analysis of more than 500 samples. It yields information on accumulating substances with rather low molecular masses. related to protein. amino acid and nucleic acid metabolisn~.
About 75 samples can be analyzed weekly, enabling studies in which a large number of samples are to be investigated, such as patient heterogeneity, longitudinal, time-concentration, and in vivo and in vitro dialysis studies. Here. only nine solutes were 'quantitated' by peak height. However, it seems possible to quantitate 15-20 substances, in a single run HPLC gradient elution analysis. aftrr appropriate identifi~ati~~n of peaks. A number of peaks were identified. but the nature of three. very characteristic and prominent peaks remains to be established. The population of uremic patients in the present study, could roughly be divided into three groups, as described in the text. Only slight longitudinal changes of the HPLC patterns of individual patients were found. These findings suggest the possibility of multivariate statistical analysis and correlation to patient specific parameters. This is presently under inv~stigati~>n and will he reported elsewhere. A comparison of in vivo dialysis efficiency in hemofiltration, hemodialysis and hemodiafiltration showed that the latter is the superior method for the removal of most solutes in the HPLC chromatograms.
Again, this in vivo dialysis ratio is only indicative for the efficiency of treatment. In vitro dialysis, and time ~on~entr~~tion studies are necessary to obtain more exact data on the behavior of these solutes in the uremic patient/artifici~~l kidney system. Individual data on dialysis ratio are presently related to and possibly corrected for, body weight, residual renal function, membrane type, protein catabolic rate etc. Selectivity data on the removal of different solutes with different dialysis strategies. variations of membrane surface area and filtration rate, as suggested earlier by Sprenger [14] , may lead to the design of, more patient-aimed, therapies.
